PTC Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

PTC Therapeutics (NASDAQ: PTCT) has announced that its CEO, Matthew B. Klein, M.D., will deliver a presentation at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Monday, January 13, 2025, at 11:15 a.m. PST / 2:15 p.m. EST.

The event will be accessible via webcast on PTC Therapeutics' website under the Investors section's Events and Presentations page. Viewers can access the webcast at https://ir.ptcbio.com/events-presentations, and the recording will remain available for 30 days after the presentation. Attendees are advised to connect several minutes before the start time to ensure proper connection.

News Market Reaction – PTCT

-1.47%

-1.47% Session move

In the trading session that priced this news, PTCT declined 1.47%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WARREN, N.J., Dec. 23, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that CEO Matthew B. Klein, M.D., will present at the 43^rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, at 11:15 a.m. PST / 2:15 p.m. EST.

The presentation will be webcast live on the Events and Presentations page under the Investors section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection. 

About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, Instagram, LinkedIn and X.

For More Information:

Investors:
Ellen Cavaleri
+1 (615) 618-6228
ecavaleri@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302338079.html

SOURCE PTC Therapeutics, Inc.

FAQ

When is PTC Therapeutics (PTCT) presenting at the 2025 J.P. Morgan Healthcare Conference?

PTC Therapeutics will present on Monday, January 13, 2025, at 11:15 a.m. PST / 2:15 p.m. EST.

How long will PTCT's J.P. Morgan Healthcare Conference presentation be available for viewing?

The presentation webcast will be archived and available for 30 days following the live presentation.

Where can investors watch PTC Therapeutics' J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation webcast on PTC's website at https://ir.ptcbio.com/events-presentations under the Investors section's Events and Presentations page.

Who will be presenting for PTCT at the 2025 J.P. Morgan Healthcare Conference?

Matthew B. Klein, M.D., CEO of PTC Therapeutics, will be presenting at the conference.